Anodyne| 3-MMC | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 177.24 g/mol [1] |
| Predicted LogP | 2 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H15NO [1] |
| IUPAC name | 2-(methylamino)-1-(3-methylphenyl)propan-1-one [1] |
| SMILES | CC1=CC(=CC=C1)C(=O)C(C)NC [1] |
| InChI | InChI=1S/C11H15NO/c1-8-5-4-6-10(7-8)11(13)9(2)12-3/h4-7,9,12H,1-3H3 [1] |
| InChIKey | QDNXSIYWHYGMCD-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | 50 min (in pigs) |
| Dosing[] |
|---|
| Insufflated [] | |
|---|---|
| Light | ≤ 80.6 mg |
| Common | 80.6 - 98 mg |
| Strong | 98 - 120 mg |
| Heavy | 120 - 140 mg |
| Extreme | 140 mg + |
| Intravenous [] | |
|---|---|
| Light | ≤ 65 mg |
| Common | 65 - 80 mg |
| Strong | 80 - 120 mg |
| Heavy | 120 - 150 mg |
| Extreme | 150 mg + |
| Oral [] | |
|---|---|
| Light | ≤ 300 mg |
| Common | 300 - 330 mg |
| Strong | 330 - 340 mg |
| Heavy | 340 - 350 mg |
| Extreme | 350 mg + |
| Intrarectal [] | |
|---|---|
| Light | ≤ 65.9 mg |
| Common | 65.9 - 75 mg |
| Strong | 75 - 100 mg |
| Heavy | 100 - 120 mg |
| Extreme | 120 mg + |
Statistically derived dosages via DBI-IGS We do not take any responsibility for medical complications or loss of life sustained by following these dosages blindly. |
Metaphedrone
Metaphedrone (also known as 3-Methylmethcathinone, 3-Mmc, 2-(methylamino)-1-(3-methylphenyl)-1-Propanone, 1-Propanone, 2-(methylamino)-1-(3-methylphenyl)-, 3-MMC, RefChem:94930, 824-776-2, 3-Methyl Methcathinone, MEPEDRONE or 3-methylmethcathinone) is a stimulant substance of the cathinone class.
Chemistry
Stereochemistry []
Metaphedrone is a racemic mixture of the enantiomers
| Stereoisomers |
|---|
Subjective effects
| Anodyne Usernotes [] | |
|---|---|
| 0xea / Metaphedrone[hydrochloride] via Intravenous, Insufflated, Subcutaneous, Oral, Intrarectal and Vaporized at 5-200mg intravenous, 25-90mg insufflated, 5mg subcutaneous, 20-75mg oral, 10-200mg intrarectal and 15-20mg vaporized |
|
Legal status
- Brazil: Metaphedrone is a F2 substance.
- United Kingdom: Metaphedrone is a Class B substance.
- United States: Metaphedrone is a Schedule I under the "Controlled Substances Act (CSA)".
- Germany: Metaphedrone is a Anlage I substance.
- United Nations: Metaphedrone is a Schedule II drug under the "Convention on Psychotropic Substances 1971".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 71741532, Metaphedrone. Accessed October 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/71741532
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Metaphedrone. UNII: 73Q9QTO1N4. Global Substance Registration System. Accessed October 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/73Q9QTO1N4